{
  "docId": "019f6b8f-1840-747c-b048-7afedf31e31d",
  "docSlug": "jarvis-ey-how-fit-is-your-capital-allocation-strategy",
  "documentTitle": "EY How fit is your capital allocation strategy",
  "authorId": "ey-how-fit-is-your-capital-allocation-strategy",
  "authorName": null,
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 14,
  "pageCount": 24,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "comparison_table",
  "function": "compare_options",
  "density": "balanced",
  "nDataPoints": 32,
  "notes": "The chart uses a mirrored bar chart structure to contrast two different industry segments.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8f-1840-747c-b048-7afedf31e31d/14",
  "deckHref": "/decks/019f6b8f-1840-747c-b048-7afedf31e31d",
  "deckJsonHref": "/decks/019f6b8f-1840-747c-b048-7afedf31e31d.json",
  "deckAnchorHref": "/decks/019f6b8f-1840-747c-b048-7afedf31e31d#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.55,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Biotech and specialty pharma capital allocation",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c3780d5-cc0a-403a-9a25-58f4234b07d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.4,
        "x": 0.05,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Big pharma capital allocation",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c5ed9e0-6af8-49b3-ab7f-c89d08d82c33",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.35,
        "y": 0.165
      },
      "kind": "legend",
      "text": "M&A (yellow), Dividends and buybacks (grey)",
      "attrs": null,
      "subkind": "legend",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "94c7ef47-21c4-4e3b-b871-ef6ecb90a078",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "Source: EY, Capital IQ and company financial data.",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b8870452-65f7-4194-84ff-6e966c25b8d3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Big pharmas return cash to shareholders; biotechs, specialty pharmas focus on M&A",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89fd92ec-a292-401a-bb19-2bb3d863180e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "1df4edfc-5a50-4a76-9035-17e677e45b96",
      "evidence": "Big pharmas return cash to shareholders; biotechs, specialty pharmas focus on M&A",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "capital-allocation-framework",
      "slug": null,
      "matchId": "dd357c8b-f25b-42a5-82f0-75ab9738b81c",
      "evidence": "The slide explicitly compares M&A vs Dividends/Buybacks as capital allocation strategies.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 7,
      "beatId": "2ee61659-cd45-4e64-8c84-7f31031fa91a",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The document provides data and analysis to support its claims.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}